프리미어 신약 개발 서비스로 워크플로 최적화
효율적인 신약 개발을 위해서는 강력한 완전 통합형 데이터 소스가 필요합니다. 새로운 CAS BioFinder Discovery Platform™을 포함한 CAS 솔루션으로 전보다 훨씬 더 빠르게 깊이있는 통찰력을 확보할 수 있습니다.
생명 과학 뉴스레터 구독 신청
Address critical risks at every stage of drug discovery
From target validation to lead optimization, our solutions work together to streamline drug discovery while minimizing risk.
Identify high-value targets by exploring curated disease, biomarker, and protein information with CAS BioFinder.
Learn more about CAS BioFinderRefine leads with SAR insights, predictive bioactivity models, and MMPA visualizations using CAS BioFinder.
Learn more about CAS BioFinderBreak down your data silos and reveal pipeline insights by partnering with data experts through CAS Custom Services.
Learn more about CAS Custom ServicesDevelop synthesis plans and find suppliers that meet your needs with CAS SciFinder.
Learn more about CAS SciFinderStop making critical decisions with incomplete information
Drug discovery requires comprehensive biological, clinical, toxicological, and chemical data in one place. CAS unifies the key insights your team needs to innovate quickly.
- Unify cross-functional data from chemistry, biology, and clinical research into one connected environment.
- Enable flexible discovery with AI-ready data that integrates seamlessly into your analytics and workflows.
- Minimize guesswork with trustworthy insights powered by the CAS Content Collection™.
See how our life sciences data is built for your team’s success.

The current state of drug discovery: Is there a better way forward?
Time constraints force drug discovery scientists to choose between thoroughness and speed. Our white paper examines how teams are overcoming these challenges to innovate better and faster.

Frequently asked questions
How does CAS support the drug discovery workflow?
CAS has multiple solutions, mainly CAS BioFinder and CAS SciFinder, that are equipped with expertly curated insights and cutting-edge features to assist drug discovery teams at every step in their workflow.
What ROI can I expect from using CAS BioFinder in my drug discovery workflow?
CAS BioFinder helps your teams reduce time spent on low-potential targets, minimize safety risks, and select candidates faster. This improves the likelihood of successful outcomes and keeps costs down.
Can CAS BioFinder reduce the risk of late-stage drug failure?
Yes. CAS BioFinder enables early risk predictions, which helps teams avoid costly missteps and improve target selection before reaching clinical trials.
How does CAS help with drug discovery R&D?
R&D teams generate a massive amount of complex data. Our CAS Custom Services team helps make that data usable by integrating it with our world-leading curated data in the CAS Content Collection. By unlocking the most relevant information and collaborating with you on ways to solve your unique challenges, we help you identify more promising candidates to get to market faster.
Related articles

Is your pharmaceutical product development taking too long?
